{
    "organizations": [],
    "uuid": "7b8057ee9e7eeadc0a47d916cf6cfeb0504a6c5c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-innovus-pharmaceuticals-reports-q4/brief-innovus-pharmaceuticals-reports-q4-loss-per-share-0-01-idUSASC09UJ7",
    "ord_in_thread": 0,
    "title": "BRIEF-Innovus Pharmaceuticals Reports Q4 Loss Per Share $0.01",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Innovus Pharmaceuticals Inc:\n* INNOVUS PHARMACEUTICALS REPORTS RECORD ANNUAL REVENUE FOR FISCAL 2017 OF $8.8 MILLION, PRELIMINARY Q1 2018 REVENUE OF $4.3 MILLION TO $4.4 MILLION AND EXPECTS TO EXIT 2018 PROFITABLE\n* Q4 REVENUE ROSE 40.7 PERCENT TO $2.4 MILLION * SEES Q1 2018 REVENUE $4.3 MILLION TO $4.4 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T04:20:00.000+03:00",
    "crawled": "2018-04-03T15:57:49.117+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "innovus",
        "pharmaceutical",
        "inc",
        "innovus",
        "pharmaceutical",
        "report",
        "record",
        "annual",
        "revenue",
        "fiscal",
        "million",
        "preliminary",
        "q1",
        "revenue",
        "million",
        "million",
        "expects",
        "exit",
        "profitable",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "see",
        "q1",
        "revenue",
        "million",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}